PATENT CLAIM ANALYSIS

Application Number: 15940544
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "373000"]

Abstract:
The invention relates to novel ebsulfur analogues and novel pharmaceutical compositions comprising ebsulfur analogues. The invention also relates to novel methods of treating infections caused by fungal species comprising administration of ebselen, ebsulfur, and ebsulfur analogues.

Claim (Index 7):
A compound of  claim 1 , wherein: X is S; Y is N; R 1  is selected from the group consisting of \u2014H, \u2014OH, \u2014NH 2 , \u2014OR b , CF 3 , NO 2 , or CN; R is selected from the group consisting of substituted alkyl, unsubstituted alkyl, and OR a ; R a  is selected from the group consisting of linear C 1-16  alkyl groups, branched C 1-16  alkyl groups, or linear pegylated C 4-16  alkyl groups; or a salt thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14430308', '14888022', '14620997', '10791425', '13519439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039043051051337
- 35 USC 102 Novelty (BERT): 0.5073200633644444
- Combined Prediction Score: 0.7742458809310648
- Mean Citation Score: 252.884558
- Max Citation Score: 272.8221
- Similarity Product: 191.7500165565133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test